Warren Buffett has a knack for picking winners to invest in with his company Berkshire Hathaway (NYSE: BRK.A, BRK.B). With plenty of patience and the Oracle of Omaha's time-tested value investing strategy, he buys businesses that others would eschew and then waits for them to blossom into multi-baggers as years pass. Usually, Buffett stocks don't skyrocket in the course of a year -- but there's a recent exception to that rule which might be worth considering.

McKesson (NYSE: MCK) makes up a mere 0.25% of Buffett's portfolio, accounting for "just" $894.5 million in value, but it's one of the world's most influential medical distribution businesses. What's more, its shares are up by more than 44% this year, smashing the market's loss of 11%. Is now a good time to follow Buffett into making an investment? 

The first thing to know about McKesson is that it has a few canonical Buffett stock attributes, starting with its relatively stable growth over time. In the last 10 years, its trailing 12-month revenue climbed by 119% with a steady and largely uninterrupted pace to top an almost unimaginably large sum of $268.4 billion. To accomplish that, it distributed medicines, hospital and clinical supplies of all types, practice management software, and a smorgasbord of other types of products that healthcare companies might need to provide care.

Continue reading

Source Fool.com